Microangiopathy in Diabetes
Microangiopathy IN Diabetes
Karolinska Institutet
400 participants
Mar 1, 2024
OBSERVATIONAL
Conditions
Summary
This clinical trial aims to evaluate the use of a contactless and non-invasive technique to measure the properties of the skin's microcirculation and its regulatory functions in both healthy individuals and patients with microvascular disease associated with type 1 diabetes. It is hoped that the study results will lead to the development of a useful method for detecting diabetic complications at an early stage, thereby enabling treatment and preventive measures before the onset of severe microangiopathy.
Eligibility
Inclusion Criteria1
- Diabetes mellitus type 1.
Exclusion Criteria5
- Patients unable to understand patient information due to cognitive impairment.
- Patients unable to understand patient information due to language barriers.
- Ongoing acute infection disease or inflammatory condition.
- Pregnant or breast-feeding women.
- Patients with damaged and/or scarred tissue in the areas of interest for the investigational or comparator devices.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07145567